Vinland Capital Management Gestora de Recursos LTDA. Makes New $995,000 Investment in Agilent Technologies, Inc. (NYSE:A)

Vinland Capital Management Gestora de Recursos LTDA. bought a new position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 6,700 shares of the medical research company's stock, valued at approximately $995,000. Agilent Technologies accounts for about 2.3% of Vinland Capital Management Gestora de Recursos LTDA.'s investment portfolio, making the stock its 3rd largest holding.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Crewe Advisors LLC raised its holdings in Agilent Technologies by 114.8% in the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company's stock valued at $25,000 after buying an additional 101 shares during the period. Livelsberger Financial Advisory purchased a new position in shares of Agilent Technologies during the 3rd quarter worth approximately $28,000. Ridgewood Investments LLC acquired a new stake in Agilent Technologies in the 2nd quarter valued at approximately $29,000. Fortitude Family Office LLC lifted its stake in Agilent Technologies by 68.3% during the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company's stock worth $35,000 after purchasing an additional 95 shares in the last quarter. Finally, Ashton Thomas Private Wealth LLC acquired a new stake in shares of Agilent Technologies in the second quarter valued at $39,000. 87.42% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, SVP Dominique Grau sold 9,990 shares of the company's stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares of the company's stock, valued at approximately $5,801,595. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the firm's stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now owns 40,011 shares in the company, valued at approximately $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the transaction, the chief executive officer now directly owns 24,118 shares of the company's stock, valued at $3,497,110. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 11,995 shares of company stock worth $1,739,510. 0.33% of the stock is currently owned by insiders.

Agilent Technologies Price Performance

Shares of A traded down $0.73 during mid-day trading on Thursday, hitting $130.76. The company's stock had a trading volume of 699,697 shares, compared to its average volume of 1,676,547. The firm has a 50-day simple moving average of $140.01 and a 200 day simple moving average of $138.12. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $37.57 billion, a P/E ratio of 27.28, a P/E/G ratio of 6.96 and a beta of 1.05. Agilent Technologies, Inc. has a 1-year low of $100.26 and a 1-year high of $155.35.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the company earned $1.43 EPS. The company's quarterly revenue was down 5.6% on a year-over-year basis. Analysts predict that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were given a $0.236 dividend. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 annualized dividend and a dividend yield of 0.72%. Agilent Technologies's payout ratio is 19.50%.

Wall Street Analysts Forecast Growth

A has been the subject of several research reports. Citigroup boosted their price target on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a "buy" rating in a research note on Thursday, August 22nd. Wells Fargo & Company started coverage on shares of Agilent Technologies in a report on Tuesday, August 27th. They issued an "overweight" rating and a $157.00 target price on the stock. Evercore ISI increased their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an "in-line" rating in a research report on Tuesday, October 1st. UBS Group raised their price objective on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a "neutral" rating in a report on Thursday, August 22nd. Finally, Barclays boosted their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an "underweight" rating in a research note on Tuesday, October 15th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat.com, Agilent Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $144.36.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.